Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babette Schade

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Cancer Research|October 7, 2010
Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune responseJosie Ursini-Siegel, Sean Cory, Dongmei Zuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Cancer Research|October 7, 2010
Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune responseJosie Ursini-Siegel, Sean Cory, Dongmei Zuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Pageof 2